SHIRAI Mutsunori

J-GLOBAL         Last updated: Mar 6, 2019 at 03:58
 
Avatar
Name
SHIRAI Mutsunori
URL
http://mb.med.yamaguchi-u.ac.jp/
Affiliation
Yamaguchi University
Section
Graduate School of Medicine Intelligent and Analytical Medical Sciences(Medicine) Graduate School of Medicine(Medicine) YAMAGUCHI UNIVERSITY
Job title
Professor
Degree
(BLANK)(The University of Tokyo)
Other affiliation
Yamaguchi UniversityYamaguchi University
Research funding number
20196596

Research Areas

 
 

Academic & Professional Experience

 
Apr 2016
 - 
Today
Vice-president, University Evaluation, Yamaguchi University
 
Aug 2000
 - 
Today
Professor, Graduate School of Medicine(Medicine), YAMAGUCHI UNIVERSITY
 
Dec 1989
   
 
Associate Researcher, Ministry of Education, Nationai Institutes of Health(NIH),National Cancer Institute(NCI)
 
Nov 1990
   
 
Visiting Associate, Vaccine Research Section, Metabolism Branch, National Institutes of Health
 

Education

 
Mar 1985
   
 
University of Tokyo
 
Apr 1981
   
 
Graduate School, Division of Medicine, The University of Tokyo
 

Published Papers

 
Hanaoka N, Matsutani M, Satoh M, Ogawa M, Shirai M, Ando S
Japanese journal of infectious diseases   70(1) 119-123   Jan 2017   [Refereed]
Rahman MA, Shirai M, Aziz MA, Ushirokita R, Kubota S, Suzuki H, Azuma Y
Apoptosis : an international journal on programmed cell death   20(10) 1271-1280   Oct 2015   [Refereed]
Matsutani M, Ito K, Azuma Y, Ogino H, Shirai M, Yakushi T, Matsushita K
Applied microbiology and biotechnology   99(17) 7229-7240   Sep 2015   [Refereed]
Tamehiro N, Oda H, Shirai M, Suzuki H
PloS one   10(6) e0131047   2015   [Refereed]
Akada J, Kamei S, Ito A, Ito M, Kitagawa T, Furumoto H, Kato Y, Tamesa M, Takashima M, Shirai M, Yamano H, Oka M, Kuramitsu Y, Nakamura K
Proteome science   11(1) 33   Jul 2013   [Refereed]
Hasegawa A, Iwamura C, Kitajima M, Hashimoto K, Otsuyama K, Ogino H, Nakayama T, Shirai M
PloS one   8(6) e65494   2013   [Refereed]
Matsutani M, Ogawa M, Takaoka N, Hanaoka N, Toh H, Yamashita A, Oshima K, Hirakawa H, Kuhara S, Suzuki H, Hattori M, Kishimoto T, Ando S, Azuma Y, Shirai M
PloS one   8(9) e71861   2013   [Refereed]
Ogino H, Azuma Y, Hosoyama A, Nakazawa H, Matsutani M, Hasegawa A, Otsuyama K, Matsushita K, Fujita N, Shirai M
Journal of bacteriology   193(24) 6997-6998   Dec 2011   [Refereed]
Katagiri T, Hatano N, Aihara M, Kawano H, Okamoto M, Liu Y, Izumi T, Maekawa T, Nakamura S, Ishihara T, Shirai M, Mizukami Y
Proteome science   8 41   Jul 2010   [Refereed]
Hasegawa A, Hayashi K, Kishimoto H, Yang M, Tofukuji S, Suzuki K, Nakajima H, Hoffman RM, Shirai M, Nakayama T
The Journal of allergy and clinical immunology   125(2) 461-468.e6   Feb 2010   [Refereed]
Whole-genome analyses reveal genetic instability of Acetobacter pasteurianus.
Azuma Y, Hosoyama A, Matsutani M, Furuya N, Horikawa H, Harada T, Hirakawa H, Kuhara S, Matsushita K, Fujita N, Shirai M.
37(17) 5768-5783   Sep 2009   [Refereed]
Gasp, a Grb2-associating protein, is critical for positive selection of thymocytes.
Patrick MS1, Oda H, Hayakawa K, Sato Y, Eshima K, Kirikae T, Iemura S, Shirai M, Abe T, Natsume T, Sasazuki T, Suzuki H.
Proc Natl Acad Sci U S A.   106(38) 16345-16350   Sep 2009   [Refereed]
Hosokawa T, Hasegawa A, Iwamura C, Shinoda K, Tofukuji S, Watanabe Y, Hosokawa H, Motohashi S, Hashimoto K, Shirai M, Yamashita M, Nakayama T.
Journal of Immunology   183(12) 8203-15   2009   [Refereed]
Inhibitory effect of proton pump inhibitors against chemotaxis of Helicobacter pylori
Nakamura H, Yoshiyama H, Yanai H, Shiral M, Nakazawa T, Okita K
120(5) 655-656   2001   [Refereed]
Synthesis of hepatitis B virus core antigen polypeptide in E.coli using pKK233-3 plasmid, a vector for expression with tac promoter.
Shirai M, WatanabeS., Nishioka M.
Japanese J. Exp. Med,   60 97-103   1990   [Refereed]
Inhibitory effects of hepatitis B virus antigen on induction of lymphokine-activated killer cell activity.
Shirai, M., S. Watanabe and M. Nishioka.
Liver   10 302-12   1990   [Refereed]
Peripheral blood CD4-mediated enhancement and CD8-mediated suppression in the presence of recombinant hepatitis B virus core antigen.
Shirai, M., H.Hanada, K. Kurokouchi, S. Watanabe and M. Nishioka.
J. Infect. Diseases   161 420-25   1990   [Refereed]
Antitumoral effect of intratumoral injection of human recombinant interleukin-2 in patients with hepatocellular carcinoma : a preliminary report.
Shirai, M., S. Watanabe and M. Nishioka.
Euro. J. Cancer   26 1045-48   1990   [Refereed]
Intratumoral injection of OK-432 and lymphokine-activated killer activity in peripheral blood of patients with hepatocellular carcinoma.
Shirai, M., S. Watanabe and M. Nishioka.
Euro. J. Cancer   26 965-69   1990   [Refereed]
Protective effect of OK-432(streptococcal preparation) on murine fulminant hepatitis following mouse hepatitis virus infection.
Shirai, M., S. Watanabe and M. Nishioka.
J. Gastroenterol. Hepatol.   5 395-401   1990   [Refereed]
Broad recognition of cytotoxic T cell epitopes from the HIV-1 enverope protein with multiple class I histocompatibility molecules.
Shirai, M., C.D. Pendoleton and J.A.Berzofsky.
J. Immunol   148 1657-67   1992   [Refereed]
Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein.
Shirai M, Akatsuka T, Pendleton CD, Houghten R, Wychowski C, Mihalik K, Feinstone S, Berzofsky JA.
J Virol.   66(7) 4098-106   1992   [Refereed]
Preferential Vb usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
Shirai,M., M.S. Vacchio, R.J. Hodes and J.A. Berzofsky.
J. Immunol   151 2283-95   1993   [Refereed]
Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides.
Kozlowski, S., M. Corr, M. Shirai, L.F. Boyd, C.D. Pendleton, J.A. Berzofsky, D.H. Margulies.
J. Immunol   151 4033-44   1993   [Refereed]
Actor, J., M. Shirai, M. Kullberg, R.M.L. Buller, A. Sher and J.A. Berzofsky.
Proc.Natl.Acad.Sci.USA.   90 948-52   1993   [Refereed]
Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
Shirai M, Pendleton CD, Ahlers J, Takeshita T, Newman M, Berzofsky JA.
J Immunol.   152(2) 549-56   1994   [Refereed]
An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and human
Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten R, Pendleton CD, Feinstone SM, Berzofsky JA.
J Virol.   68(5) 3334-42   1994   [Refereed]
CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA.
J Immunol.   154(6) 2733-42   Mar 1995   [Refereed]
Electron microscopic studies of peripheral blood mononuclear cells in chronic type C hepatitis treated with interferon-alpha.
Watanabe S, Ito T, Shirai M, Arima K, Nishioka M, Saito T, Ohbayashi M.
Ultrastruct Pathol.   19(1) 1-8   1995   [Refereed]
Czaja AJ, Ming C, Shirai M, Nishioka M.
J Hepatol.   23(1) 32-8   1995   [Refereed]
Reciprocal cytotoxic T lymphocyete cross-reactivity interactions between two major epitopes withtn HIV-1
Shirai M, Kurokohchi K, Pendleton CD, Arichi T, Boyd LF, Takahashi H, Margulies DH, Berzofsky JA.
J Immunol.   157(10) 4399-411   1996   [Refereed]
Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
Shirai M, Chen M, Arichi T, Masaki T, Nishioka M, Newman M, Nakazawa T, Feinstone SM, Berzofsky JA.
J Infect Dis.   173(1) 24-31   1996   [Refereed]
Masaki T, Tokuda M, Ohnishi M, Watanabe S, Fujimura T, Miyamoto K, Itano T, Matsui H, Arima K, Shirai M, Maeba T, Sogawa K, Konishi R, Taniguchi K, Hatanaka Y, Hatase O, Nishioka M.
Hepatology   24(1) 72-81   1996   [Refereed]
Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop
Shirai M, Kozlowski S, Margulies DH, Berzofsky JA.
J Immunol.   158(7) 3181-8   1997   [Refereed]
Characterization of anti-histone antibodies in patients with type 1 autoimmune hepatitis.
Chen M, Shirai M, Czaja AJ, Kurokohchi K, Arichi T, Arima K, Kodama T, Nishioka M.
J Gastroenterol Hepatol.   13(5) 483-9   1998   [Refereed]
Persistent infection by Helicobacter pylori down-modulates virus-specific CD8+ cytotoxic T cell response and prolongs viral infection.
Shirai M, Arichi T, Nakazawa T, Berzofsky JA.
J Infect Dis.   177(1) 72-80   1998   [Refereed]
Nucleotide sequence and characterization of cdrA, a cell division-related gene of Helicobacter pylori.
Takeuchi H, Shirai M, Akada JK, Tsuda M, Nakazawa T.
J Bacteriol.   180(19) 5263-8   1998   [Refereed]
Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery.
Yamashita K, Ouchi K, Shirai M, Gondo T, Nakazawa T, Ito H.
Stroke   29(4) 773-8   1998   [Refereed]
Chlamydia pneumoniae in coronary and ilica arteries of Japanese patients with atherosclerotic cardiovascular disease
Ouchi, K., B. Fujii, Y. Kanamoto, M. Karita, M. Shirai, and T. Nakazawa.
Journal of Medical Microbiology   47(10) 907-913   1998   [Refereed]
Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells.
Chen M, Shirai M, Liu Z, Arichi T, Takahashi H, Nishioka M.
J Virol.   72(10) 8301-8   1998   [Refereed]
T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.
Shirai M, Arichi T, Chen M, Masaki T, Nishioka M, Ikeda K, Takahashi H, Enomoto N, Saito T, Major ME, Nakazawa T, Akatsuka T, Feinstone SM, Berzofsky JA.
J Immunol.   162(1) 568-76   1999   [Refereed]
Shirai M, Fujinaga R, Akada JK, Nakazawa T.
Gene   239(2) 351-9   1999   [Refereed]
Masaki T, Okada M, Tokuda M, Shiratori Y, Hatase O, Shirai M, Nishioka M, Omata M.
Hepatology   29(2) 379-84   1999   [Refereed]
In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657.
Akada JK, Shirai M, Fujii K, Okita K, Nakazawa T.
Antimicrob Agents Chemother.   43(5) 1072-1076   1999   [Refereed]
Lymphotoxin inhibits chlamydia pneumoniae Growth in Hep-2 cells
Matsushima H, Shirai M, Ouchi K, Yamashita K, Kakutani T, Furukawa S, Nakazawa T.
Infect Immun.   67(6) 3175-3179   1999   [Refereed]
Chlamydia pneumoniae in Atherosclerotic and Nonatherosclerotic Tissue.
Ouchi K, Fujii B, Kudo S, Shirai M, Yamashita K, Gondo T, Ishihara T, Ito H, Nakazawa T.
J Infect Dis.   181(Suppl 3) 441-443   2000   [Refereed]
Comparison of Outer Membrane Protein Genes omp and pmp in the Whole Genome Sequences of Chlamydia pneumoniae Isolates from Japan and the United States.
Shirai M, Hirakawa H, Ouchi K, Tabuchi M, Kishi F, Kimoto M, Takeuchi H, Nishida J, Shibata K, Fujinaga R, Yoneda H, Matsushima H, Tanaka C, Furukawa S, Miura K, Nakazawa A, Ishii K, Shiba T, Hattori M, Kuhara S, Nakazawa T.
J Infect Dis.   181(Suppl 3) 524-5247   2000   [Refereed]
Kersulyte D, Mukhopadhyay AK, Velapatiño B, Su W, Pan Z, Garcia C, Hernandez V, Valdez Y, Mistry RS, Gilman RH, Yuan Y, Gao H, Alarcón T, López-Brea M, Balakrish Nair G, Chowdhury A, Datta S, Shirai M, Nakazawa T, Ally R, Segal I, Wong BC, Lam SK, Olfat FO, Borén T, Engstrand L, Torres O, Schneider R, Thomas JE, Czinn S, Berg DE.
J Bacteriol.   182(11) 3210-8   2000   [Refereed]
Kersulyte D, Mukhopadhyay AK, Shirai M, Nakazawa T, Berg DE.
J. Bacteriol   182(19) 5300-8   2000   [Refereed]
Shirai M, Hirakawa H, Kimoto M, Tabuchi M, Kishi F, Ouchi K, Shiba T, Ishii K, Hattori M, Kuhara S, Nakazawa T.
Nucleic Acids Res.   28(12) 2311-4   2000   [Refereed]
Masaki T, Tokuda M, Shiratori Y, Shirai M, Matsumoto K, Nishioka M, Omata M.
J Hepatol.   32(1) 92-9   2000   [Refereed]
Akada JK, Shirai M, Takeuchi H, Tsuda M, Nakazawa T.
Mol Microbiol.   36(5) 1071-84   2000   [Refereed]
Yoshimatsu T, Shirai M, Nagata K, Okita K, Nakazawa T.
Dig Dis Sci.   45(9) 1747-53   2000   [Refereed]
Accumulation of polyphosphate granules in Helicobacter pylori cells under anaerobic conditions.
Shirai M, Kakada J, Shibata K, Morshed MG, Matsushita T, Nakazawa T.
J Med Microbiol.   49(6) 513-9   2000   [Refereed]
Miura K, Inouye S, Sakai K, Takaoka H, Kishi F, Tabuchi M, Tanaka T, Matsumoto H, Shirai M, Nakazawa T, Nakazawa A.
J. Biol. Chem   276(16) 13490-8   2001   [Refereed]
Fujinaga R, Nakazawa T, Shirai M.
J Infect Chemother.   7(3) 148-55   2001   [Refereed]
Kido Y, Shirai M, Ouchi K, Nakazawa T.
J. Infect. Chemotherapy   7(3) 180-5   2001   [Refereed]
Okamoto T, Yoshiyama H, Nakazawa T, Park ID, Chang MW, Yanai H, Okita K, Shirai M.
J Antimicrob Chemother.   50(6) 849-56   2002   [Refereed]
Toh H, Miura K, Shirai M, Hattori M.
DNA Res.   10(1) 9-17   2003   [Refereed]
Yoneda H, Miura K, Matsushima H, Sugi K, Murakami T, Ouchi K, Yamashita K, Itoh H, Nakazawa T, Suzuki M, Shirai M.
J Med Microbiol.   52(Pt 5) 409-15   2003   [Refereed]
Komura H, Matsushima H, Ouchi K, Shirai M, Nakazawa T, Furukawa S.
J Infect Chemother.   9(2) 160-4   2003   [Refereed]
Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, Tei C, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H; Japanese Acute Coronary Syndrome Study Investigators.
Am J Cardiol.   92(7) 840-3   2003   [Refereed]
Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y.
Br J Haematol.   124(1) 91-6   2004   [Refereed]
Inouye S, Izu H, Takaki E, Suzuki H, Shirai M, Yokota Y, Ichikawa H, Fujimoto M, Nakai A.
J Biol Chem.   279(37) 38701-9   2004   [Refereed]
Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Tei C, Hiraoka H, Sonoda M, Tsuchihashi K, Yamagishi M, Inoue T, Asada Y, Ikeda Y, Shirai M, Ogawa H; Japanese Acute Coronary Syndrome Study investigators.
Ann Med.   36(2) 153-60   2004   [Refereed]
Fukuoka K, Sawabe A, Sugimoto T, Koga M, Okuda H, Kitayama T, Shirai M, Komai K, Komemushi S, Matsuda K.
J Agric Food Chem.   52(20) 6326-9   2004   [Refereed]
Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H; Japanese Acute Coronary Syndrome Study Investigators.
Am Heart J.   150(4) 814-20   2005   [Refereed]
Rahman MA, Azuma Y, Fukunaga H, Murakami T, Sugi K, Fukushi H, Miura K, Suzuki H, Shirai M.
J Antimicrob Chemother.   56(5) 861-8   2005   [Refereed]
Kosuge M, Kimura K, Kojima S, Sakamoto T, Matsui K, Ishihara M, Asada Y, Tei C, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H; Japanese Acute Coronary Syndrome Study (JACSS) Investigators.
Circ J.   69(4) 375-9   2005   [Refereed]
Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, Tei C, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H; Japanese Acute Coronary Syndrome Study (JACSS) Investigators.
Circ J.   69(6) 630-5   2005   [Refereed]
Azuma Y, Hirakawa H, Yamashita A, Cai Y, Rahman MA, Suzuki H, Mitaku S, Toh H, Goto S, Murakami T, Sugi K, Hayashi H, Fukushi H, Hattori M, Kuhara S, Shirai M.
DNA Res.   13(1) 15-23   2006   [Refereed]
Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer.
Yano S, Matsuyama H, Hirata H, Inoue R, Matsumoto H, Ohmi C, Miura K, Shirai M, Iizuka N, Naito K.
Oncol Rep.   15(6) 1453-60   2006   [Refereed]
Sakai K, Suzuki H, Oda H, Akaike T, Azuma Y, Murakami T, Sugi K, Ito T, Ichinose H, Koyasu S, Shirai M.
J Biol Chem.   281(26) 17736-42   2006   [Refereed]
Takeuchi H, Nakazawa T, Okamoto T, Shirai M, Kimoto M, Nishioka M, Con SA, Morimoto N, Sugiura T.
Microbiol Immunol.   50(7) 487-97   2006   [Refereed]
Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, Tei C, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H; Japanese Acute Coronary Syndrome Study (JACSS) Investigators.
Circ J.   70(3) 217-21   2006   [Refereed]
Oda H, Suzuki H, Sakai K, Kitahara S, Patrick MS, Azuma Y, Sugi K, Kitamura T, Kaye J, Shirai M.
J Leukoc Biol.   81(2) 500-8   2007   [Refereed]
Genome-wide analysis of Chlamydophila pneumoniae gene expression at the late stage of infection.
Miura K, Toh H, Hirakawa H, Sugii M, Murata M, Nakai K, Tashiro K, Kuhara S, Azuma Y, Shirai M.
DNA Res.   15(2) 83-91   2008   [Refereed]
Okuda H, Sakuhana C, Yamamoto R, Mizukami Y, Kawai R, Sumita Y, Koga M, Shirai M, Matsuda K.
J Biol Chem.   283(14) 9300-7   2008   [Refereed]
Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, Tei C, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Shirai M, Hiraoka H, Honda T, Ogata Y, Ogawa H; Japanese Acute Coronary Syndrome Study (JACSS) Investigators.
Circ J.   72(4) 521-5   2008   [Refereed]
Kosuge M, Kimura K, Morita S, Kojima S, Sakamoto T, Ishihara M, Asada Y, Tei C, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Shirai M, Hiraoka H, Honda T, Ogata Y, Ogawa H; Japanese Acute Coronary Syndrome Study (JACSS) Investigators.
Am J Cardiol.   103(3) 322-7   2009   [Refereed]
Sato Y, Oda H, Patrick MS, Baba Y, Rus'd AA, Azuma Y, Abe T, Shirai M, Suzuki H.
Immunol Lett   124(1) 27-34   2009   [Refereed]
RhoH plays critical roles in Fc epsilon RI-dependent signal transduction in mast cells.
Oda H, Fujimoto M, Patrick MS, Chida D, Sato Y, Azuma Y, Aoki H, Abe T, Suzuki H, Shirai M.
J Immunol.   182(2) 957-62   2009   [Refereed]
Organ distribution of 3H-endotoxin in rats with liver fibrosis and rats with liver cirrhosis.
Shirai M, A Yoshimura, M Nishioka, J Shiga, W Mori, I Fukuda and S Kanegasaki
36 172-174   1989   [Refereed]
Effects of human recombinant interleukin 2 in patients with chronic hepatitis B : A preliminary report.
Nishioka M, H Kagawa, M Shirai, S Terada and S Watanabe.
American J Gastroenterol,   82 438-442   1987   [Refereed]
A light and scanning electron microscopic study of hepatic venoocclusive disease.
Shirai M, K Nagashima,S Iwasaki and W Mori.
Acta Pathol.Jpn,(現Pathology International)   37 1961-1971   1987   [Refereed]
A study of the mechanism of acute hepatic necrosis following partial resection of the liver.
Shirai M, J Shiga and W Mori.
Acta Pathol.Jpn,(現Pathology International)   37 1127-1134   1987   [Refereed]
Fate of 3H-labeled endotoxin in partially hepatectomised rats.
Shirai M, M Nishioka, J Shiga, W Mori, I Fukuda and S Kanegasaki.
Hepato-Gastroenterol,   35 107-110   1988   [Refereed]

Books etc

 
ハリソン内科学第17版日本語版 第3版
SHIRAI Mutsunori (Part:Joint Translation, 感染症Section10 Rickettsia、MycoplasmaおよびChlamydiaによる疾患159 Mycopklasma 感染症)
Mar 2009